{"url":"https://lda.senate.gov/api/v1/filings/76fb0b2f-7fdf-4e2c-bbc1-2f026dc2add0/","filing_uuid":"76fb0b2f-7fdf-4e2c-bbc1-2f026dc2add0","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/76fb0b2f-7fdf-4e2c-bbc1-2f026dc2add0/print/","filing_document_content_type":"text/html","income":null,"expenses":"250000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jeremy Allen","dt_posted":"2025-01-21T13:10:58-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3737 Market Street, Suite 1300","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Philadelphia","registrant_state":"PA","registrant_zip":"19104","registrant":{"id":401104534,"url":"https://lda.senate.gov/api/v1/registrants/401104534/","house_registrant_id":null,"name":"SPARK THERAPEUTICS, INC.","description":"biotechnology","address_1":"3737 Market Street, Suite 1300","address_2":null,"address_3":null,"address_4":null,"city":"Philadelphia","state":"PA","state_display":"Pennsylvania","zip":"19104","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEREMY ALLEN","contact_telephone":"+1 202-276-0808","dt_updated":"2026-01-24T14:43:32.109360-05:00"},"client":{"id":201988,"url":"https://lda.senate.gov/api/v1/clients/201988/","client_id":12,"name":"SPARK THERAPEUTICS, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, issues related to PRV and the Accelerating Kids Access to Care Act. Issues related to the CMMI demonstration on Gene and Cell Therapy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66725,"prefix":null,"prefix_display":null,"first_name":"JEREMY","nickname":null,"middle_name":null,"last_name":"ALLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115162,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":"M.","last_name":"MCAULIFFE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to gene therapy and rare diseases. H.R. 4758 - Accelerating Kids Access to Care Act, all provisions. H.R. 3433 - Give Kids a Chance Act of 2024, all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66725,"prefix":null,"prefix_display":null,"first_name":"JEREMY","nickname":null,"middle_name":null,"last_name":"ALLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115162,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":"M.","last_name":"MCAULIFFE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}